Aktuell 13 mai 2024 Kanton Zug fördert Institut für Blockchain-Forschung Der Kanton Zug beteiligt sich an den Aufbaukosten eines Instituts für Blockchain-Forschung. Für das Projekt der Universität Luzern und der Hochsc...
News 17 abr 2024 Symbio invests CHF 12 million in new research facility in Corminboeuf Symbio commits CHF 12 million to establish a high-tech hydrogen research center in Corminboeuf, aiming for a 2026 launch.
News 24 mai 2024 Geistlich receives EU certification for collagen portfolio Geistlich Pharma has received MDR certification for its collagen product range and thus meets the new EU requirements. The products will be used ...
News 13 mai 2024 Canton of Zug funds institute for blockchain research The canton of Zug is contributing to the costs of setting up an institute for blockchain research. The project of the University of Lucerne and L...
News 10 mai 2024 BioVersys extends Series C financing round to 44.9 million Swiss francs BioVersys is bolstering its partnership with GSK in order to accelerate the development of alpibectir for the treatment of tuberculosis. GSK is s...
News 18 out 2023 Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings Valais-based pharmaceutical companies Lonza and Siegfried have been recognized among the leading players in the global outsourcing landscape, wit...
Actualités 11 out 2023 Lonza élargit davantage ses capacités de fabrication d’ADC à Viège Lonza amplifie sa production d’ADC via une extension importante de la capacité de bioconjugaison de son Ibex Dedicate Biopark à Viège, ce qui dev...
Press Release 15 dez 2022 Swiss technology for digital worlds For the fifth time in a row, Switzerland is taking part in the Consumer Electronics Show (CES) in Las Vegas. Under the motto "swisstech for exten...
News 11 jan 2023 Bachem Group secures CHF 1 billion peptide supply contract Bachem Group's recent CHF 1 billion peptide supply deal, spanning over five years will enable the company's plans to expand capacity across all i...
News 29 set 2023 Top Stories from Western Switzerland (July-September 2023) From spearheading eco-innovative solutions to pioneering breakthroughs in solar technology, cancer research, sustainable shipping, and the realms...
News 10 out 2023 MSD commits to Lucerne as a business location MSD Switzerland has its sights set on further growth from its Lucerne location. Since being founded 60 years ago, the pharmaceutical company has ...
News 02 ago 2023 Neuchâtel: the new Swiss crypto haven At the heart of Western Switzerland, a revolution is quietly brewing. Where most would expect the bustling financial hubs of Geneva or Zug to spe...
News 18 dez 2017 New conformity assessment procedure in the United Arab Emirates The new conformity assessment covers restrictions on the use of hazardous ingredients in electronic and electrical goods (RoHS: Restriction of Ha...
News 19 jun 2017 FAQ: Introduction of Value Added Tax in the United Arab Emirates Recently, the six member states of the Gulf Cooperation Council, including the United Arab Emirates (UAE), have agreed on the introduction of Val...
News 01 dez 2021 Sun Genomics sets up European subsidiary in Fribourg Probiotics specialist Sun Genomics has chosen Fribourg to set up its European subsidiary. This is the first establishment of a US company in West...
News 13 set 2021 Incyte inaugurates its new production plant in Yverdon After establishing its European headquarters in Morges in 2020, American biopharmaceutical group Incyte strengthens its presence in the canton of...
News 30 set 2021 Basel Area becomes the Swiss hotspot for Chinese pharma companies More and more Chinese pharmaceutical companies are choosing the Basel Area as location for their subsidiary in Switzerland. Among them is Hengrui...
News 12 jun 2023 Lonza boosts next-generation anticancer drugs with CHF 97 million investment in Visp Pharma giant Lonza is enhancing its capabilities in the development of novel cancer treatments through an investment of over CHF 97 million in Vi...